Polyrizon Ltd

Polyrizon insider sales reveal confidence: executives sell shares, keep restricted stakes, and maintain a 6 % ownership stake—investors see a steady, yet cautious, growth outlook.

Polyrizon insiders’ strategic holdings signal confidence ahead of 2026 human trials for its nasal hydrogel platform.